{"id":"https://openalex.org/W7165388013","doi":"https://doi.org/10.6084/m9.figshare.32740740","title":"Supplementary Material for: Para-coumaric acid suppresses VEGF-induced DLL4\u2013NOTCH1 signaling, tumor angiogenesis, and tumor growth","display_name":"Supplementary Material for: Para-coumaric acid suppresses VEGF-induced DLL4\u2013NOTCH1 signaling, tumor angiogenesis, and tumor growth","publication_year":2026,"publication_date":"2026-06-19","ids":{"openalex":"https://openalex.org/W7165388013","doi":"https://doi.org/10.6084/m9.figshare.32740740"},"language":"en","primary_location":{"id":"pmh:oai:figshare.com:article/32740740","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Material_for_Para-coumaric_acid_suppresses_VEGF-induced_DLL4_NOTCH1_signaling_tumor_angiogenesis_and_tumor_growth/32740740","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/dataset/Supplementary_Material_for_Para-coumaric_acid_suppresses_VEGF-induced_DLL4_NOTCH1_signaling_tumor_angiogenesis_and_tumor_growth/32740740","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5137570570","display_name":"figshare admin karger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162602","display_name":"Karger Publishers (Switzerland)","ror":"https://ror.org/0572q5a45","country_code":"CH","type":"company","lineage":["https://openalex.org/I2802626578","https://openalex.org/I40120149","https://openalex.org/I4210162602"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"karger, figshare admin","raw_affiliation_strings":["Karger Publishers (Switzerland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karger Publishers (Switzerland)","institution_ids":["https://openalex.org/I4210162602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139007868","display_name":"Ha S.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S., Ha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139015706","display_name":"You J.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J., You","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138996514","display_name":"Bae S.H.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S.H., Bae","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139025530","display_name":"Kim H.-G.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H.-G., Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024239495","display_name":"Nam\u2010In Baek","orcid":"https://orcid.org/0000-0002-9438-2817","observed_orcids":["https://orcid.org/0000-0002-9438-2817"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N.-I., Baek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139021309","display_name":"Jeong J.-H.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.-H., Jeong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138982274","display_name":"Kim J.A.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.A., Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5138970649","display_name":"Lee Y.M.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y.M., Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10268","display_name":"Developmental Biology and Gene Regulation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p-coumaric-acid","display_name":"p-coumaric acid","score":1.0},{"id":"https://openalex.org/keywords/delta-like-ligand-4","display_name":"DLL4","score":0.7120000123977661},{"id":"https://openalex.org/keywords/notch1-signaling","display_name":"Notch1 signaling","score":0.984000027179718},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8140000104904175},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.9879999756813049},{"id":"https://openalex.org/keywords/natural-compounds","display_name":"natural compounds","score":0.6330000162124634},{"id":"https://openalex.org/keywords/endothelial-cells","display_name":"endothelial cells","score":0.8939999938011169},{"id":"https://openalex.org/keywords/vascular-normalization","display_name":"vascular normalization","score":0.7009999752044678},{"id":"https://openalex.org/keywords/lewis-lung-carcinoma","display_name":"Lewis lung carcinoma","score":0.8769999742507935},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.843999981880188},{"id":"https://openalex.org/keywords/pericyte-coverage","display_name":"pericyte coverage","score":0.8100000023841858},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8100000023841858},{"id":"https://openalex.org/keywords/cd3-t-cell-infiltration","display_name":"CD3+ T cell infiltration","score":0.7639999985694885},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.597000002861023}],"concepts":[{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.7023000121116638},{"id":"https://openalex.org/C123012128","wikidata":"https://www.wikidata.org/wiki/Q5376430","display_name":"Endothelial stem cell","level":3,"score":0.6202999949455261},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6040999889373779},{"id":"https://openalex.org/C2777847059","wikidata":"https://www.wikidata.org/wiki/Q6537255","display_name":"Lewis lung carcinoma","level":4,"score":0.5073000192642212},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4341000020503998},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4253000020980835},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.40639999508857727},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.40549999475479126},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.390500009059906},{"id":"https://openalex.org/C2776992346","wikidata":"https://www.wikidata.org/wiki/Q111140","display_name":"Endothelium","level":2,"score":0.35280001163482666},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.33090001344680786},{"id":"https://openalex.org/C2778939058","wikidata":"https://www.wikidata.org/wiki/Q4046167","display_name":"CD31","level":3,"score":0.3082999885082245},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.3075999915599823},{"id":"https://openalex.org/C150710994","wikidata":"https://www.wikidata.org/wiki/Q18034921","display_name":"Vascular endothelial growth inhibitor","level":5,"score":0.3046000003814697},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.3021000027656555},{"id":"https://openalex.org/C179926584","wikidata":"https://www.wikidata.org/wiki/Q207714","display_name":"Transcription (linguistics)","level":2,"score":0.296999990940094},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.2969000041484833},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.2939000129699707},{"id":"https://openalex.org/C2778271429","wikidata":"https://www.wikidata.org/wiki/Q1281049","display_name":"Neovascularization","level":3,"score":0.27790001034736633},{"id":"https://openalex.org/C2780427682","wikidata":"https://www.wikidata.org/wiki/Q500446","display_name":"Pericyte","level":4,"score":0.2621000111103058},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2542000114917755}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:figshare.com:article/32740740","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Material_for_Para-coumaric_acid_suppresses_VEGF-induced_DLL4_NOTCH1_signaling_tumor_angiogenesis_and_tumor_growth/32740740","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.32740740","doi":"https://doi.org/10.6084/m9.figshare.32740740","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.32740740","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.32740740.v1","doi":"https://doi.org/10.6084/m9.figshare.32740740.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.32740740.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/32740740","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Material_for_Para-coumaric_acid_suppresses_VEGF-induced_DLL4_NOTCH1_signaling_tumor_angiogenesis_and_tumor_growth/32740740","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7165370463","https://openalex.org/W4392678502","https://openalex.org/W2076274098","https://openalex.org/W4399423065","https://openalex.org/W4290479641","https://openalex.org/W7098659647","https://openalex.org/W2153726848","https://openalex.org/W2040827891","https://openalex.org/W3021227184","https://openalex.org/W2073465941"],"abstract_inverted_index":{"Introduction:":[0],"DLL4\u2013NOTCH1":[1,115,231],"signaling":[2,85,165,232],"mediates":[3],"juxtacrine":[4],"communication":[5,59],"between":[6],"tip-":[7],"and":[8,27,60,69,83,99,109,126,139,163,175,188,201,210,215,240,250],"stalk-like":[9],"endothelial":[10,20,38,58,87,168,184,234],"cells":[11],"during":[12],"vascular":[13,202,243],"sprouting,":[14],"contributing":[15],"to":[16,33,48,61,77],"complementary":[17],"aspects":[18],"of":[19,25,55,113,173],"function.":[21],"Thus,":[22],"simultaneous":[23],"modulation":[24,65],"DLL4":[26,82,96,161],"NOTCH1":[28,84,164],"may":[29],"provide":[30],"a":[31,50,90,95,100,224],"strategy":[32],"broadly":[34],"interfere":[35],"with":[36,170],"the":[37,114,151,192],"functions":[39],"involved":[40],"in":[41,86,135,140,167,233,246,254],"tumor":[42,67,147,199,208,216,248],"angiogenesis.":[43],"Accordingly,":[44],"this":[45],"study":[46],"aims":[47],"identify":[49,78],"novel":[51],"natural":[52,75,154,225],"compound":[53,226,267],"capable":[54],"modulating":[56],"DLL4\u2013NOTCH1-mediated":[57],"investigate":[62],"how":[63],"such":[64],"influences":[66],"angiogenesis":[68,137],"growth.":[70],"Methods:":[71],"We":[72,117,132],"screened":[73,153],"66":[74,152],"compounds":[76],"those":[79],"that":[80,93,227,259],"suppress":[81],"cells.":[88],"Using":[89],"dual-reporter":[91],"system":[92],"combines":[94],"promoter-driven":[97],"reporter":[98],"CSL":[101],"luciferase":[102],"reporter,":[103],"we":[104],"simultaneously":[105],"assessed":[106],"ligand-associated":[107],"activity":[108,166],"downstream":[110],"transcriptional":[111],"output":[112],"axis.":[116],"confirmed":[118],"VEGF-induced":[119,183],"target":[120],"gene":[121],"expression":[122],"via":[123],"western":[124],"blotting":[125],"quantitative":[127],"real-time":[128],"polymerase":[129],"chain":[130],"reaction.":[131],"further":[133,262],"performed":[134],"vitro":[136],"assays":[138],"vivo":[141],"Lewis":[142],"lung":[143],"carcinoma":[144],"(LLC)":[145],"allograft":[146,194],"experiments.":[148],"Results:":[149],"Among":[150],"compounds,":[155],"para-coumaric":[156],"acid":[157],"(p-CA)":[158],"dose-dependently":[159],"suppressed":[160,182,198],"transcription":[162],"cells,":[169,235],"IC50":[171],"values":[172],"4.57":[174],"8.34":[176],"\u00b5M,":[177],"respectively.":[178],"Furthermore,":[179],"p-CA":[180,196,222,260],"significantly":[181],"cell":[185,217],"proliferation,":[186],"migration,":[187],"tube":[189],"formation.":[190],"In":[191,220],"LLC":[193],"model,":[195],"treatment":[197],"growth":[200],"density,":[203],"increased":[204],"pericyte":[205],"coverage,":[206],"reduced":[207],"hypoxia,":[209],"enhanced":[211,251],"CD3+":[212],"T-cell":[213],"infiltration":[214],"apoptosis.":[218],"Conclusion:":[219],"summary,":[221],"is":[223],"functionally":[228],"suppresses":[229],"VEGF-driven":[230],"exhibiting":[236],"strong":[237],"anti-angiogenic":[238,266],"effects":[239],"promoting":[241],"functional":[242],"normalization,":[244],"resulting":[245],"marked":[247],"suppression":[249],"antitumor":[252],"immunity":[253],"vivo.":[255],"These":[256],"findings":[257],"suggest":[258],"warrants":[261],"investigation":[263],"as":[264],"an":[265],"for":[268],"cancer":[269],"therapy.":[270]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-06-20T00:00:00"}